Tryp Therapeutics Reaches Milestone on Psilocybin Drug Manufacturing Program
Tryp Therapeutics Reaches Milestone on Psilocybin Drug Manufacturing Program La Jolla, California–(Newsfile Corp. – February 16, 2021) – Tryp Therapeutics
Read more
RATINGS1
Neovasc Announces Closing of US$72 Million Registered Direct Offering of Common Shares Priced At-The-Market
Neovasc Announces Closing of US$72 Million Registered Direct Offering of Common Shares Priced At-The-Market Vancouver, British Columbia–(Newsfile Corp. – February
Read more